Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 16 May, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 524598 | NSE: AKSHARCHEM

AksharChem (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 15, 2025, 10:12 pm

Market Cap 190 Cr.
Current Price 241
High / Low 376/193
Stock P/E
Book Value 325
Dividend Yield0.21 %
ROCE3.85 %
ROE6.96 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for AksharChem (India) Ltd

Competitors of AksharChem (India) Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Dynamic Industries Ltd 28.5 Cr. 94.0 124/65.028.2 1570.53 %0.04 %0.49 % 10.0
Daikaffil Chemicals India Ltd 98.4 Cr. 164 281/83.9 16.10.00 %12.2 %12.2 % 10.0
Amal Ltd 682 Cr. 552 830/29623.3 80.20.00 %36.0 %34.6 % 10.0
Vidhi Specialty Food Ingredients Ltd 2,271 Cr. 449 572/38252.1 60.50.78 %18.7 %14.9 % 1.00
Ushanti Colour Chem Ltd 61.8 Cr. 55.0 68.4/47.2 38.60.00 %0.21 %5.88 % 10.0
Industry Average1,498.00 Cr335.6044.26165.000.29%9.29%8.09%8.13

All Competitor Stocks of AksharChem (India) Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 89.73111.96114.5190.5264.9164.7471.6873.3075.2881.7985.9178.9390.69
Expenses 78.47109.03108.2885.0262.9163.0572.3576.5070.3481.3679.6772.9184.37
Operating Profit 11.262.936.235.502.001.69-0.67-3.204.940.436.246.026.32
OPM % 12.55%2.62%5.44%6.08%3.08%2.61%-0.93%-4.37%6.56%0.53%7.26%7.63%6.97%
Other Income 0.130.210.040.010.020.070.040.020.280.100.060.220.07
Interest 0.820.960.980.820.740.670.800.880.981.071.251.321.34
Depreciation 3.053.093.203.243.243.173.353.493.473.473.463.513.51
Profit before tax 7.52-0.912.091.45-1.96-2.08-4.78-7.550.77-4.011.591.411.54
Tax % 30.32%-395.60%30.62%31.72%-27.55%-5.77%12.55%0.79%57.14%50.37%27.67%26.24%22.08%
Net Profit 5.232.681.460.98-1.42-1.97-5.38-7.600.33-6.021.151.041.19
EPS in Rs 6.383.341.821.22-1.77-2.45-6.70-9.460.41-7.491.431.291.48

Last Updated: February 28, 2025, 8:43 pm

Below is a detailed analysis of the quarterly data for AksharChem (India) Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is 90.69 Cr.. The value appears strong and on an upward trend. It has increased from 78.93 Cr. (Sep 2024) to 90.69 Cr., marking an increase of 11.76 Cr..
  • For Expenses, as of Dec 2024, the value is 84.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 72.91 Cr. (Sep 2024) to 84.37 Cr., marking an increase of 11.46 Cr..
  • For Operating Profit, as of Dec 2024, the value is 6.32 Cr.. The value appears strong and on an upward trend. It has increased from 6.02 Cr. (Sep 2024) to 6.32 Cr., marking an increase of 0.30 Cr..
  • For OPM %, as of Dec 2024, the value is 6.97%. The value appears to be declining and may need further review. It has decreased from 7.63% (Sep 2024) to 6.97%, marking a decrease of 0.66%.
  • For Other Income, as of Dec 2024, the value is 0.07 Cr.. The value appears to be declining and may need further review. It has decreased from 0.22 Cr. (Sep 2024) to 0.07 Cr., marking a decrease of 0.15 Cr..
  • For Interest, as of Dec 2024, the value is 1.34 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.32 Cr. (Sep 2024) to 1.34 Cr., marking an increase of 0.02 Cr..
  • For Depreciation, as of Dec 2024, the value is 3.51 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 3.51 Cr..
  • For Profit before tax, as of Dec 2024, the value is 1.54 Cr.. The value appears strong and on an upward trend. It has increased from 1.41 Cr. (Sep 2024) to 1.54 Cr., marking an increase of 0.13 Cr..
  • For Tax %, as of Dec 2024, the value is 22.08%. The value appears to be improving (decreasing) as expected. It has decreased from 26.24% (Sep 2024) to 22.08%, marking a decrease of 4.16%.
  • For Net Profit, as of Dec 2024, the value is 1.19 Cr.. The value appears strong and on an upward trend. It has increased from 1.04 Cr. (Sep 2024) to 1.19 Cr., marking an increase of 0.15 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 1.48. The value appears strong and on an upward trend. It has increased from 1.29 (Sep 2024) to 1.48, marking an increase of 0.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:21 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 96145200188248264323260246380335302337
Expenses 90112172155171223288234223349319301318
Operating Profit 633273278423426243215219
OPM % 6%23%14%17%31%16%11%10%10%8%5%0%6%
Other Income 0-231975111000
Interest 2133311112345
Depreciation 11445567712131414
Profit before tax 3292426794333191718-0-161
Tax % -12%31%32%36%33%28%32%18%28%11%88%20%
Net Profit 4201617533123161216-1-19-3
EPS in Rs 7.6540.4621.8822.7572.3737.2627.5419.1615.2419.81-1.17-23.25-3.29
Dividend Payout % 7%12%16%15%5%9%13%18%23%3%-43%-2%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)400.00%-20.00%6.25%211.76%-41.51%-25.81%-30.43%-25.00%33.33%-106.25%-1800.00%
Change in YoY Net Profit Growth (%)0.00%-420.00%26.25%205.51%-253.27%15.70%-4.63%5.43%58.33%-139.58%-1693.75%

AksharChem (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:8%
5 Years:-1%
3 Years:7%
TTM:18%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:82%
Stock Price CAGR
10 Years:7%
5 Years:4%
3 Years:-9%
1 Year:-7%
Return on Equity
10 Years:8%
5 Years:2%
3 Years:-1%
Last Year:-7%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:44 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 5577788888888
Reserves 12296478133230249257271272270251253
Borrowings 149243132012131550255268
Other Liabilities 13275139476147456276627069
Total Liabilities 4470146155219299316323356406365380398
Fixed Assets 162155566586126128229231225235230
CWIP 00249263162616171130
Investments 081822517721100000
Other Assets 2841717294110138131120159122135138
Total Assets 4470146155219299316323356406365380398

Below is a detailed analysis of the balance sheet data for AksharChem (India) Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
  • For Reserves, as of Sep 2024, the value is 253.00 Cr.. The value appears strong and on an upward trend. It has increased from 251.00 Cr. (Mar 2024) to 253.00 Cr., marking an increase of 2.00 Cr..
  • For Borrowings, as of Sep 2024, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 52.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 16.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is 69.00 Cr.. The value appears to be improving (decreasing). It has decreased from 70.00 Cr. (Mar 2024) to 69.00 Cr., marking a decrease of 1.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is 398.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 380.00 Cr. (Mar 2024) to 398.00 Cr., marking an increase of 18.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is 230.00 Cr.. The value appears to be declining and may need further review. It has decreased from 235.00 Cr. (Mar 2024) to 230.00 Cr., marking a decrease of 5.00 Cr..
  • For CWIP, as of Sep 2024, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 30.00 Cr., marking an increase of 19.00 Cr..
  • For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
  • For Other Assets, as of Sep 2024, the value is 138.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Mar 2024) to 138.00 Cr., marking an increase of 3.00 Cr..
  • For Total Assets, as of Sep 2024, the value is 398.00 Cr.. The value appears strong and on an upward trend. It has increased from 380.00 Cr. (Mar 2024) to 398.00 Cr., marking an increase of 18.00 Cr..

Notably, the Reserves (253.00 Cr.) exceed the Borrowings (68.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +22228134130-92649438-7
Cash from Investing Activity +-0-14-13-11-32-63-2-20-49-24-8-16
Cash from Financing Activity +-2-8-15-2-5337-7118-3023
Net Cash Flow-000-03-0-4-01-100

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-8.0024.003.001.0046.0042.0022.0013.009.00-18.00-10.00-50.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days313438442038434242513957
Inventory Days19495354102686510414811599131
Days Payable63901119610070496297806488
Cash Conversion Cycle-13-7-19222355983938675100
Working Capital Days5439467164569812297897897
ROCE %17%85%34%27%53%21%13%7%6%6%1%-4%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters62.70%61.40%62.70%62.70%62.70%62.70%62.70%62.70%62.70%62.70%62.70%62.70%
FIIs1.46%1.43%1.55%1.45%1.44%0.72%0.68%0.68%0.68%0.68%0.43%0.39%
DIIs0.06%0.06%0.05%0.05%0.06%0.06%0.06%0.06%0.06%0.06%0.06%0.06%
Public35.78%37.11%35.70%35.80%35.81%36.52%36.56%36.56%36.56%36.57%36.82%36.87%
No. of Shareholders14,75316,15015,76515,77615,81915,72215,32915,00715,50615,26715,11914,629

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 16Mar 15
FaceValue 10.0010.00
Basic EPS (Rs.) 22.7521.88
Diluted EPS (Rs.) 22.7521.88
Cash EPS (Rs.) 28.5527.22
Book Value[Excl.RevalReserv]/Share (Rs.) 116.2497.70
Book Value[Incl.RevalReserv]/Share (Rs.) 116.2497.70
Revenue From Operations / Share (Rs.) 256.85273.48
PBDIT / Share (Rs.) 45.8340.36
PBIT / Share (Rs.) 40.0335.02
PBT / Share (Rs.) 35.4530.57
Net Profit / Share (Rs.) 22.7521.88
NP After MI And SOA / Share (Rs.) 22.7521.88
PBDIT Margin (%) 17.8414.75
PBIT Margin (%) 15.5812.80
PBT Margin (%) 13.8011.17
Net Profit Margin (%) 8.858.00
NP After MI And SOA Margin (%) 8.858.00
Return on Networth / Equity (%) 19.5722.39
Return on Capital Employeed (%) 29.3231.30
Return On Assets (%) 10.7210.92
Long Term Debt / Equity (X) 0.070.02
Total Debt / Equity (X) 0.330.32
Asset Turnover Ratio (%) 1.250.00
Current Ratio (X) 1.281.08
Quick Ratio (X) 0.980.79
Inventory Turnover Ratio (X) 6.240.00
Dividend Payout Ratio (NP) (%) 15.3815.99
Dividend Payout Ratio (CP) (%) 12.2512.85
Earning Retention Ratio (%) 84.6284.01
Cash Earning Retention Ratio (%) 87.7587.15
Interest Coverage Ratio (X) 10.029.07
Interest Coverage Ratio (Post Tax) (X) 5.975.56
Enterprise Value (Cr.) 147.77137.44
EV / Net Operating Revenue (X) 0.780.68
EV / EBITDA (X) 4.414.66
MarketCap / Net Operating Revenue (X) 0.630.57
Retention Ratios (%) 84.6184.00
Price / BV (X) 1.411.62
Price / Net Operating Revenue (X) 0.630.57
EarningsYield 0.130.13

After reviewing the key financial ratios for AksharChem (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
  • For Diluted EPS (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
  • For Cash EPS (Rs.), as of Mar 16, the value is 28.55. This value is within the healthy range. It has increased from 27.22 (Mar 15) to 28.55, marking an increase of 1.33.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 116.24. It has increased from 97.70 (Mar 15) to 116.24, marking an increase of 18.54.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 116.24. It has increased from 97.70 (Mar 15) to 116.24, marking an increase of 18.54.
  • For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 256.85. It has decreased from 273.48 (Mar 15) to 256.85, marking a decrease of 16.63.
  • For PBDIT / Share (Rs.), as of Mar 16, the value is 45.83. This value is within the healthy range. It has increased from 40.36 (Mar 15) to 45.83, marking an increase of 5.47.
  • For PBIT / Share (Rs.), as of Mar 16, the value is 40.03. This value is within the healthy range. It has increased from 35.02 (Mar 15) to 40.03, marking an increase of 5.01.
  • For PBT / Share (Rs.), as of Mar 16, the value is 35.45. This value is within the healthy range. It has increased from 30.57 (Mar 15) to 35.45, marking an increase of 4.88.
  • For Net Profit / Share (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
  • For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
  • For PBDIT Margin (%), as of Mar 16, the value is 17.84. This value is within the healthy range. It has increased from 14.75 (Mar 15) to 17.84, marking an increase of 3.09.
  • For PBIT Margin (%), as of Mar 16, the value is 15.58. This value is within the healthy range. It has increased from 12.80 (Mar 15) to 15.58, marking an increase of 2.78.
  • For PBT Margin (%), as of Mar 16, the value is 13.80. This value is within the healthy range. It has increased from 11.17 (Mar 15) to 13.80, marking an increase of 2.63.
  • For Net Profit Margin (%), as of Mar 16, the value is 8.85. This value is within the healthy range. It has increased from 8.00 (Mar 15) to 8.85, marking an increase of 0.85.
  • For NP After MI And SOA Margin (%), as of Mar 16, the value is 8.85. This value is within the healthy range. It has increased from 8.00 (Mar 15) to 8.85, marking an increase of 0.85.
  • For Return on Networth / Equity (%), as of Mar 16, the value is 19.57. This value is within the healthy range. It has decreased from 22.39 (Mar 15) to 19.57, marking a decrease of 2.82.
  • For Return on Capital Employeed (%), as of Mar 16, the value is 29.32. This value is within the healthy range. It has decreased from 31.30 (Mar 15) to 29.32, marking a decrease of 1.98.
  • For Return On Assets (%), as of Mar 16, the value is 10.72. This value is within the healthy range. It has decreased from 10.92 (Mar 15) to 10.72, marking a decrease of 0.20.
  • For Long Term Debt / Equity (X), as of Mar 16, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 15) to 0.07, marking an increase of 0.05.
  • For Total Debt / Equity (X), as of Mar 16, the value is 0.33. This value is within the healthy range. It has increased from 0.32 (Mar 15) to 0.33, marking an increase of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 16, the value is 1.25. It has increased from 0.00 (Mar 15) to 1.25, marking an increase of 1.25.
  • For Current Ratio (X), as of Mar 16, the value is 1.28. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 15) to 1.28, marking an increase of 0.20.
  • For Quick Ratio (X), as of Mar 16, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.79 (Mar 15) to 0.98, marking an increase of 0.19.
  • For Inventory Turnover Ratio (X), as of Mar 16, the value is 6.24. This value is within the healthy range. It has increased from 0.00 (Mar 15) to 6.24, marking an increase of 6.24.
  • For Dividend Payout Ratio (NP) (%), as of Mar 16, the value is 15.38. This value is below the healthy minimum of 20. It has decreased from 15.99 (Mar 15) to 15.38, marking a decrease of 0.61.
  • For Dividend Payout Ratio (CP) (%), as of Mar 16, the value is 12.25. This value is below the healthy minimum of 20. It has decreased from 12.85 (Mar 15) to 12.25, marking a decrease of 0.60.
  • For Earning Retention Ratio (%), as of Mar 16, the value is 84.62. This value exceeds the healthy maximum of 70. It has increased from 84.01 (Mar 15) to 84.62, marking an increase of 0.61.
  • For Cash Earning Retention Ratio (%), as of Mar 16, the value is 87.75. This value exceeds the healthy maximum of 70. It has increased from 87.15 (Mar 15) to 87.75, marking an increase of 0.60.
  • For Interest Coverage Ratio (X), as of Mar 16, the value is 10.02. This value is within the healthy range. It has increased from 9.07 (Mar 15) to 10.02, marking an increase of 0.95.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is 5.97. This value is within the healthy range. It has increased from 5.56 (Mar 15) to 5.97, marking an increase of 0.41.
  • For Enterprise Value (Cr.), as of Mar 16, the value is 147.77. It has increased from 137.44 (Mar 15) to 147.77, marking an increase of 10.33.
  • For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.68 (Mar 15) to 0.78, marking an increase of 0.10.
  • For EV / EBITDA (X), as of Mar 16, the value is 4.41. This value is below the healthy minimum of 5. It has decreased from 4.66 (Mar 15) to 4.41, marking a decrease of 0.25.
  • For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 15) to 0.63, marking an increase of 0.06.
  • For Retention Ratios (%), as of Mar 16, the value is 84.61. This value exceeds the healthy maximum of 70. It has increased from 84.00 (Mar 15) to 84.61, marking an increase of 0.61.
  • For Price / BV (X), as of Mar 16, the value is 1.41. This value is within the healthy range. It has decreased from 1.62 (Mar 15) to 1.41, marking a decrease of 0.21.
  • For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 15) to 0.63, marking an increase of 0.06.
  • For EarningsYield, as of Mar 16, the value is 0.13. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 15) which recorded 0.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of AksharChem (India) Ltd as of May 16, 2025 is: 272.01

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 16, 2025, AksharChem (India) Ltd is Undervalued by 12.87% compared to the current share price 241.00

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of AksharChem (India) Ltd as of May 16, 2025 is: 150.12

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 16, 2025, AksharChem (India) Ltd is Overvalued by 37.71% compared to the current share price 241.00

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -44.81%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 22.17%, which is a positive sign.
  2. The company has higher reserves (182.23 cr) compared to borrowings (26.54 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (255.69 cr) and profit (21.23 cr) over the years.
  1. The stock has a high average Working Capital Days of 75.92, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 43.00, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AksharChem (India) Ltd:
    1. Net Profit Margin: 8.85%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 29.32% (Industry Average ROCE: 9.29%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 19.57% (Industry Average ROE: 8.09%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 5.97
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.98
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 0 (Industry average Stock P/E: 44.26)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.33
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

AksharChem (India) Ltd. is a Public Limited Listed company incorporated on 04/07/1989 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24110GJ1989PLC012441 and registration number is 012441. Currently Company is involved in the business activities of Manufacture of dyes and pigments from any source in basic form or as concentrate. Company's Total Operating Revenue is Rs. 302.05 Cr. and Equity Capital is Rs. 8.03 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Dyes & PigmentsAkshar House, Chhatral Kadi Road, Mehsana Gujarat 382715cs@aksharchemindia.com
http://www.aksharchemindia.com
Management
NamePosition Held
Mrs. Paru M JaykrishnaChairperson & Managing Director
Mr. Munjal M JaykrishnaJoint Managing Director & CEO
Mr. Gokul M JaykrishnaNon Executive Director
Mr. Ashok D BarotExecutive Director
Mr. Jigar Mukesh PatelIndependent Director
Ms. Maitri K MehtaIndependent Director
Mr. Nirav K ShahAdditional Director
Mr. Sameer S SinhaAdditional Director
Mr. Keyur D GandhiAdditional Director
Mr. Sachin M JaykrishnaAdditional Director

FAQ

What is the intrinsic value of AksharChem (India) Ltd?

AksharChem (India) Ltd's intrinsic value (as of 16 May 2025) is ₹272.01 — 12.87% higher the current market price of 241.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 190 Cr. market cap, FY2025-2026 high/low of ₹376/193, reserves of 253 Cr, and liabilities of 398 Cr.

What is the Market Cap of AksharChem (India) Ltd?

The Market Cap of AksharChem (India) Ltd is 190 Cr..

What is the current Stock Price of AksharChem (India) Ltd as on 16 May 2025?

The current stock price of AksharChem (India) Ltd as on 16 May 2025 is 241.

What is the High / Low of AksharChem (India) Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of AksharChem (India) Ltd stocks is ₹376/193.

What is the Stock P/E of AksharChem (India) Ltd?

The Stock P/E of AksharChem (India) Ltd is .

What is the Book Value of AksharChem (India) Ltd?

The Book Value of AksharChem (India) Ltd is 325.

What is the Dividend Yield of AksharChem (India) Ltd?

The Dividend Yield of AksharChem (India) Ltd is 0.21 %.

What is the ROCE of AksharChem (India) Ltd?

The ROCE of AksharChem (India) Ltd is 3.85 %.

What is the ROE of AksharChem (India) Ltd?

The ROE of AksharChem (India) Ltd is 6.96 %.

What is the Face Value of AksharChem (India) Ltd?

The Face Value of AksharChem (India) Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in AksharChem (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE